Effectiveness and safety of daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: Systematic review and meta-analysis.
about
Patient-reported outcomes with direct-acting antivirals for the treatment of chronic hepatitis C: current knowledge and outstanding issues.Direct Acting Antiviral Agents in Korean Patients with Chronic Hepatitis C and Hemophilia Who Are Treatment-Naïve or Treatment-Experienced.Real-world efficacy of daclatasvir and asunaprevir with respect to resistance-associated substitutions.Daclatasvir and asunaprevir treatment in patients infected by genotype 1b of hepatitis C virus with no or subtle resistant associated substitutions (RAS) in NS5A-Y93.2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C
P2860
Effectiveness and safety of daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: Systematic review and meta-analysis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Effectiveness and safety of da ...... atic review and meta-analysis.
@en
type
label
Effectiveness and safety of da ...... atic review and meta-analysis.
@en
prefLabel
Effectiveness and safety of da ...... atic review and meta-analysis.
@en
P2093
P2860
P356
P1476
Effectiveness and safety of da ...... atic review and meta-analysis.
@en
P2093
P2860
P356
10.1111/JGH.13587
P577
2016-09-06T00:00:00Z